Saturday 17 October 2026
Export GOVX’s income statement to Excel — free account
GeoVax Labs Inc.
GOVX Healthcare Biotechnology
GeoVax Labs Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 million, down 37.1% from fiscal 2024. In the quarter to June 2026, revenue grew 183.4%, EPS grew 88.9% and free cash flow grew 15.8%, each against the same quarter a year earlier.
0.23
0.03
−11.54%
Follow GOVX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.75 | 1.59 | 0.56 | 1.16 | |
Current Ratio |
3.57 | 2.74 | 1.06 | 1.54 | |
Net Debt/EBITDA |
0.79 | 0.70 | 0.24 | 0.71 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.98 | 1.12 | 0.67 | 0.83 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(7.66) | (5.18) | (1.76) | (0.80) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(7.66) | (5.18) | (1.76) | (0.80) | |
Cash per Share |
6.17 | 3.22 | 0.63 | 0.69 | |
Shareholders Equity per Share |
6.05 | 3.99 | 0.25 | 0.39 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
6.05 | 3.99 | 0.25 | 0.39 | |
Free Cash Flow |
(6.21) | (4.96) | (3.54) | (3.66) | |
Working Capital |
4.69 | 3.38 | 0.14 | 1.46 | |
Capital Expenditures |
0.00 | 0.00 | — | — | |
Net Current Asset Value |
4.69 | 2.80 | (0.06) | 1.29 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Payables |
1.56 | 1.32 | 1.92 | 1.83 | |
Average Assets |
8.92 | 7.25 | 6.91 | 5.00 | |
Average Common Equity |
6.71 | 4.44 | 4.20 | 2.29 |
Columns are period end dates